In Figure 1C can be observed that RIPK1 mRNA levels were elevated in the samples from AD patients, approaching significance (p = 0.05), and reached statistically significant levels in samples from PSP patients. This evidence concerns the gene RIPK1 and supranuclear palsy, progressive, 1.